CSIMarket Company Name, Ticker, Customers, else..
 
Novo Integrated Sciences Inc   (NVOS)
 
Price: $0.0006 $0.00 -82.857%
Day's High: $0.0038999998942017555 Week Perf: 0.00
Day's Low: $ 0.00 30 Day Perf: -83.78 %
Volume (M): 49,608 52 Wk High: $ 0.06
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) 0
 Shares Outstanding (Millions) 18
 Employees 31
 Revenues (TTM) (Millions $) 13
 Net Income (TTM) (Millions $) -16
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Business Description


Novo Integrated Sciences Inc is a publicly-traded company based in Vancouver, Canada. They provide healthcare services and products aimed at improving patient outcomes and reducing healthcare costs. Novo Integrated Sciences operates through two main divisions: Novo Healthnet Limited and Novo Healthnet Rehabilitation Limited. The company's services include chronic pain management, rehabilitation, and diagnostic imaging. Novo Integrated Sciences aims to build a network of integrated healthcare clinics and partner with existing healthcare providers to deliver high-quality care.


   Company Address: 11120 NE 2nd Street Bellevue 98004 WA
   Company Phone Number: 617-9797   Stock Exchange / Ticker: NVOS


Customers Net Income grew by NVOS's Customers Net Profit Margin grew to

517.97 %
13.6 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ALSN   -6.77%    
BC   -8.66%    
BWA   -2.4%    
CMI   -3.76%    
OMTK        30% 
THRM   -2.1%    
• View Complete Report
   



Business Update

Novo Integrated Sciences Secures SBLC Confirmation from HSBC, Expands Stock Repurchase Program, and Joins Protein Ind...

Published Fri, Jun 14 2024 12:47 AM UTC

Novo Integrated Sciences Receives SBLC Confirmation from HSBC and Increases Stock Repurchase Program; Acenzia Selected for Protein Industries Canada ProgramNovo Integrated Sciences, Inc. (NASDAQ: NVOS), a leading global provider of healthcare services and solutions, has recently received confirmation from HSBC regarding the issuance of a Standby Letter of Credit (SBLC). The ...
Business Update

Novo Integrated Sciences Receives Confirmation of Issuance of SBLC by HSBC for SBLC Leasing and Monetizing Program

Published Thu, Jun 13 2024 11:47 PM UTC

Novo Integrated Sciences Secures Key Financing and Strategic Partnership for Innovation in Plant-Based Proteins BELLEVUE, Wash. Novo Integrated Sciences, Inc. (NASDAQ: NVOS), a prominent player in the integrated healthcare industry, has announced two significant developments poised to bolster its strategic initiatives. First, the Company received confirmation of the issu...
Business Update

Novo Integrated Sciences Increases Stock Repurchase Program as Revenue Declines

Published Fri, Jun 7 2024 12:38 AM UTC

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) has recently made a strategic move to increase its maximum stock repurchase program from $5 million to $10 million. This decision by the company s Board of Directors reflects the management s confidence in the long-term prospects of the company. However, this announcement comes amid a concerning decline in the company s revenue, ...
Business Update

Acenzia Secures Funding from Protein Industries Canada Program to Launch Plant-Based Protein Products

Published Thu, Jun 6 2024 12:38 AM UTC

Novo Integrated Sciences, Inc. recently announced its Canadian subsidiary, Acenzia Inc., has been chosen to participate in a groundbreaking project initiated by Protein Industries Canada. This collaboration aims to develop and introduce new plant-based protein products with an enhanced nutritional amino acid profile to the global market. The project is expected to receive a ...
Business Update

Novo Integrated Sciences Subsidiary, Acenzia, Set to Advance Plant-Based Protein Market in Partnership with Pr...

Published Wed, Jun 5 2024 8:38 PM UTC

Acenzia Selected to Participate in Protein Industries Canada Program to Develop Plant-Based Protein ProductsBELLEVUE, Wash. - Novo Integrated Sciences, Inc. (NASDAQ: NVOS) announced today that its subsidiary, Acenzia Inc., has been chosen by Protein Industries Canada for a groundbreaking project. This endeavor aims to introduce new protein products with an improved amino ac...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.00
Price to Sales (Expected) -
Price to Book 0
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.07
Working Capital Ratio 0.44
Leverage Ratio (MRQ) 1
Total Debt to Equity 0.2
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.9 $
Revenues (TTM) 0.71 $
Cash Flow (TTM) 0.02 $
Cash 0.05 $
Book Value 0.83 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 411,049
Net Income per Employee (TTM) -520,276
Receivable Turnover Ratio (TTM) 5.69
Inventory Turnover Ratio (TTM) 6.47
Asset Turnover Ratio (TTM) 0.33

Profitability Ratios Current
Gross Margin (MRQ) 34.46 %
Operating Margin (MRQ) -58.96 %
Net Margin (MRQ) 109.54 %
Net Cash Flow Margin (MRQ) -15.19 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.